Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktoria Kohlhas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Blood Advances|December 22, 2020
Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in Eµ-TCL1 miceViktoria Kohlhas, Michael Hallek, Phuong-Hien Nguyen
Leukemia Research|June 8, 2024
Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemiaHendrik Jestrabek, Viktoria Kohlhas, Michael Hallek, et al.
BMC Biotechnology|August 29, 2020
Establishing a sensitive fluorescence-based quantification method for cyclic nucleotidesNadine Gruteser, Viktoria Kohlhas, Sabine Balfanz, et al.
Journal of Leukocyte Biology|November 29, 2025
Systemic MIF facilitates chronic lymphocytic leukemia development independent of its cellular sourceViktoria Kohlhas, Nina Reinart, Natascha Rosen, et al.
EMBO Molecular Medicine|July 5, 2022
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccinationSebastian J Theobald, Alexander Simonis, Julie M Mudler, et al.
Leukemia|May 6, 2022
The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemiaLisa Rusyn, Sebastian Reinartz, Anastasia Nikiforov, et al.
Nature Communications|March 10, 2023
LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1Alexander F Vom Stein, Rocio Rebollido-Rios, Anna Lukas, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Blood Advances|December 22, 2020
Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in Eµ-TCL1 miceViktoria Kohlhas, Michael Hallek, Phuong-Hien Nguyen
Leukemia Research|June 8, 2024
Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemiaHendrik Jestrabek, Viktoria Kohlhas, Michael Hallek, et al.
BMC Biotechnology|August 29, 2020
Establishing a sensitive fluorescence-based quantification method for cyclic nucleotidesNadine Gruteser, Viktoria Kohlhas, Sabine Balfanz, et al.
Journal of Leukocyte Biology|November 29, 2025
Systemic MIF facilitates chronic lymphocytic leukemia development independent of its cellular sourceViktoria Kohlhas, Nina Reinart, Natascha Rosen, et al.
EMBO Molecular Medicine|July 5, 2022
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccinationSebastian J Theobald, Alexander Simonis, Julie M Mudler, et al.
Leukemia|May 6, 2022
The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemiaLisa Rusyn, Sebastian Reinartz, Anastasia Nikiforov, et al.
Nature Communications|March 10, 2023
LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1Alexander F Vom Stein, Rocio Rebollido-Rios, Anna Lukas, et al.
Blood Cancer Discovery|November 8, 2022
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention StrategiesRuth Flümann, Julia Hansen, Benedikt W Pelzer, et al.
Pageof 1